Member Directory

Company Profile:

Radetec Diagnostics is a Melbourne-based biotech company specialised in the development, production, and commercialisation of rapid tests. Radetec core innovations are:

• “MultiD”, a new way to detect multiple biomarkers on the same strip;
• “EasyConj”, a new type of fluorescent nanoparticle ideal for medical imaging, biomarker screening, and sensing.

Radetec is using these two technologies to develop a self-test for chlamydia and gonorrhoea, the two most prevalent sexually transmitted infections (STIs) worldwide, more sensitive than other rapid tests currently on the market.